Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lazzarin

Showing results (191-200 of 384) with videos related to

Pageof 39
Sort By:
Journal of Clinical & Laboratory Immunology|January 1, 1995
Low levels of LTB4 in cerebrospinal fluid of AIDS patients with cryptococcal meningitisM Froldi, M Parma, R Marenzi, et al.
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1995
Diagnosis of cytomegalovirus infection of the nervous system in AIDS by polymerase chain reaction analysis of cerebrospinal fluidP Cinque, L Vago, M R Terreni, et al.
Journal of Clinical & Laboratory Immunology|March 1, 1986
Chronic granulomatous disease in a 23-year-old femaleF Capsoni, F Minonzio, E Venegoni, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 15, 2009
Effect of L-acetylcarnitine on body composition in HIV-related lipodystrophyS Benedini, G Perseghin, I Terruzzi, et al.
Journal of Leukocyte Biology|September 14, 2000
Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1E Vicenzi, M Alfano, S Ghezzi, et al.
Antiviral Therapy|July 19, 2005
Study on mutations and antiretroviral therapy (SMART): preliminary resultsN Gianotti, F Moretti, G Tambussi, et al.
European Journal of Medical Research|October 26, 2011
Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label studyS Esser, A Haberl, F Mulcahy, et al.
Journal of Biological Regulators and Homeostatic Agents|October 2, 2003
Impact of HAART on liver histology of HIV/HCV coinfected patientsA De Bona, G Sitia, C Uberti-Foppa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 1998
Herpes simplex virus infections of the central nervous system in human immunodeficiency virus-infected patients: clinical management by polymerase chain reaction assay of cerebrospinal fluidP Cinque, L Vago, R Marenzi, et al.
British Journal of Addiction|May 1, 1990
Risk behaviour and HTLV-1 seropositivity in injecting drug usersG Rezza, A Lazzarin, C Uberti-Foppa, et al.
Pageof 39

Showing results (191-200 of 384) with videos related to

Sort By:
Pageof 39
Journal of Clinical & Laboratory Immunology|January 1, 1995
Low levels of LTB4 in cerebrospinal fluid of AIDS patients with cryptococcal meningitisM Froldi, M Parma, R Marenzi, et al.
Scandinavian Journal of Infectious Diseases. Supplementum|January 1, 1995
Diagnosis of cytomegalovirus infection of the nervous system in AIDS by polymerase chain reaction analysis of cerebrospinal fluidP Cinque, L Vago, M R Terreni, et al.
Journal of Clinical & Laboratory Immunology|March 1, 1986
Chronic granulomatous disease in a 23-year-old femaleF Capsoni, F Minonzio, E Venegoni, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 15, 2009
Effect of L-acetylcarnitine on body composition in HIV-related lipodystrophyS Benedini, G Perseghin, I Terruzzi, et al.
Journal of Leukocyte Biology|September 14, 2000
Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1E Vicenzi, M Alfano, S Ghezzi, et al.
Antiviral Therapy|July 19, 2005
Study on mutations and antiretroviral therapy (SMART): preliminary resultsN Gianotti, F Moretti, G Tambussi, et al.
European Journal of Medical Research|October 26, 2011
Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label studyS Esser, A Haberl, F Mulcahy, et al.
Journal of Biological Regulators and Homeostatic Agents|October 2, 2003
Impact of HAART on liver histology of HIV/HCV coinfected patientsA De Bona, G Sitia, C Uberti-Foppa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 26, 1998
Herpes simplex virus infections of the central nervous system in human immunodeficiency virus-infected patients: clinical management by polymerase chain reaction assay of cerebrospinal fluidP Cinque, L Vago, R Marenzi, et al.
British Journal of Addiction|May 1, 1990
Risk behaviour and HTLV-1 seropositivity in injecting drug usersG Rezza, A Lazzarin, C Uberti-Foppa, et al.
Pageof 39